TY  - JOUR
PY  - 1998//
TI  - Cost-effectiveness of hip fracture prevention
JO  - Epidemiologia e Prevenzione
A1  - Visentin, P.
A1  - Ciravegna, R.
A1  - Corcelli, F.
A1  - Fabris, F.
SP  - 44
EP  - 48
VL  - 22
IS  - 1
N2  - We estimated the Cost Per Avoided Hip Fracture (CPAHF, millions Lira) by osteoporosis treatment, on the basis of a review on randomized controlled trials. Prevention with vitamin D3 in institutionalized elderly women is cost-neutral (CPAHF = -4; 95% CI = -9, +5). Prevention with alendronate in non-institutionalized women screened on bone mineral density generates doubts (CPAHF = 275; 95% CI = 146, 19.426). The cost-effectiveness analyses can strengthen or weaken conclusions of the clinical trials and discourage the use of economically unsustainable preventive treatments whose efficacy is unproven.<p /> <p>Language: it</p>
LA  - it
SN  - 1120-9763
UR  - http://dx.doi.org/
ID  - ref1
ER  -